Canndeo’s mission is to be a world leader in the development of...

Canndeo’s mission is to be a world leader in the development of therapeutically superior, paramount quality and cost effective medicines derived from Cannabis sativa.We will achieve this through our end-to-end integration of essential capability and intellectual property, by investing and fostering connections through the entire value chain:
• •••Breeding of superior strains of Cannabis sativa without genetic modification
Applying superior quality management and technology approaches through plant growth, extraction and medicine production
Supporting leading research centres in understanding the therapeutic value of cannabinoids and other Cannabis sativa products, and efficiently pursuing their trial and approval as medicines
Working with doctors, pharmacies, patient support groups, governments and regulatory agencies to ensure adherence to the highest standards of care within a regulated environment.

CBD Product for Australia
Growing & Extraction Technology
(4)Following legislation to legalise the use of medicinal cannabis in 2016, Australian states will be finalising their regulatory processes throughout 2016 and early 2017. Commercial enterprises will then be able to supply CBD-based medicinal cannabis through authorised pharmacy suppliers.Following completion of this process, Canndeo will supply CBD based products into this new market. From its proposed growing and processing base in Bundaberg, Canndeo will supply products to the most stringent standards of purity and quality. In the interim, Canndeo is commencing its program of information dissemination to health professionals and interested future patients and their carers.
(5) Future Products
Several countries, particularly in the USA, have looked for several years at the commercial opportunities through a deregulated market. While this environment has different drivers to a regulated market, it has still resulted in a small number of very high quality companies emerging with innovative products and technology.Canndeo is building partnerships with leading international organisations in the medicinal cannabis space, bringing the latest developments in medicinal cannabis delivery technology. Canndeo will assess the best products for Australia in consultation with doctors, patient groups and regulators.Canndeo anticipate these partnerships will also bring near term opportunities for the clinical trial and commercial distribution of new medicines. The partnerships will also enable Canndeo to streamline its own development of products, while representing the interests of international organisations in reaching new markets in Australia.

(6) Future Developments
Canndeo has developed a unique Sandbox-Evolution-Certification model for working with leading researchers in the application of medicinal cannabis products, and fast-tracking research to identify new products that are effective, safe and whose revenues can adequately cover the extensive costs associated with clinical trials.Working closely with its research partners, Canndeo will provide a wide variety of unique strains and extracts of Cannabis sativa, and through new research findings will fast-track development of new specialised breeds for the industry. Likewise, research partners will be able to quickly determine new effectiveness of multiple cannabinoids, singly and in combination.

New medicinal cannabis products, identified in a highly cost effective manner, can then rapidly be taken through clinical trial phasesto enable new medicines in the regulated environment.

Bring on the new products, trials and subsequent sales!
Get on with the mission, it’s time!